All lobbying clients
ELI LILLY AND COMPANY
Lobbying client · District of Columbia · filed 2025 to 2026
Pharmaceutical company
$25,353,850
Reported spend
99
Filings counted
13
Outside firms hired
8
Bills named
Who filed for this client
14
- ELI LILLY AND COMPANY $20,213,850
- CHECKMATE GOVERNMENT RELATIONS $760,000
- BROWNSTEIN HYATT FARBER SCHRECK, LLP $630,000
- TIBER CREEK HEALTH STRATEGIES, INC. $560,000
- TODD STRATEGY GROUP $560,000
- FEROX STRATEGIES $420,000
- GRV STRATEGIES LLC $420,000
- TARPLIN, DOWNS & YOUNG, LLC $420,000
- MARSHALL & POPP, LLC $360,000
- WILLIAMS AND JENSEN, PLLC $350,000
- VENN STRATEGIES $310,000
- MONUMENT ADVOCACY $280,000
- THE HARPLE GROUP, LLC $70,000
- DLA PIPER LLP (US) $0
Bills named in these filings
8
Reported by year
2 years
- 2026 $11,888,850
- 2025 $13,465,000
Issues lobbied
10
Agencies and chambers lobbied
11
- SENATE
- HOUSE OF REPRESENTATIVES
- Health & Human Services, Dept of (HHS)
- Commerce, Dept of (DOC)
- Centers For Medicare and Medicaid Services (CMS)
- White House Office
- Food & Drug Administration (FDA)
- Treasury, Dept of
- Executive Office of the President (EOP)
- State, Dept of (DOS)
- U.S. Trade Representative (USTR)
Recent filings
103 total
Q3 report
View →
Q3 report
View →
Q3 report
View →
Q3 report
View →
Q3 report
View →
Q3 report
View →
Q3 reportNo activity
View →
Q3 report
View →
Q3 report
View →
Q3 report
View →
Q3 report
View →
Q3 report
View →
Q3 report
View →
Q2 report
View →
Q2 report
View →
Q2 report
View →
Q2 report
View →
Q2 report
View →
Q2 reportNo activity
View →
Q2 report
View →
VENN STRATEGIES
TODD STRATEGY GROUP
MARSHALL & POPP, LLC
WILLIAMS AND JENSEN, PLLC
TARPLIN, DOWNS & YOUNG, LLC
MONUMENT ADVOCACY
TIBER CREEK HEALTH STRATEGIES, INC.
FEROX STRATEGIES
BROWNSTEIN HYATT FARBER SCHRECK, LLP
CHECKMATE GOVERNMENT RELATIONS
GRV STRATEGIES LLC
THE HARPLE GROUP, LLC
ELI LILLY AND COMPANY
WILLIAMS AND JENSEN, PLLC
FEROX STRATEGIES
TARPLIN, DOWNS & YOUNG, LLC
MONUMENT ADVOCACY
BROWNSTEIN HYATT FARBER SCHRECK, LLP
TIBER CREEK HEALTH STRATEGIES, INC.
VENN STRATEGIES